| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.043 | 0.3 |